Doxorubicin-Induced Alterations in Anti-ROS Enzymes Activity and Cytochromes Content in Candida utilis
暂无分享,去创建一个
[1] S. Khavari-Nejad,et al. In Vitro Study of Acriflavine Interaction with Horseradish Peroxidase C , 2015 .
[2] R. Xie,et al. Mitochondria-Derived Reactive Oxygen Species Play an Important Role in Doxorubicin-Induced Platelet Apoptosis , 2015, International journal of molecular sciences.
[3] K. Tománková,et al. In vitro cytotoxicity analysis of doxorubicin-loaded/superparamagnetic iron oxide colloidal nanoassemblies on MCF7 and NIH3T3 cell lines , 2015, International journal of nanomedicine.
[4] W. Gmeiner,et al. Site-Specific DNA–Doxorubicin Conjugates Display Enhanced Cytotoxicity to Breast Cancer Cells , 2014, Bioconjugate chemistry.
[5] Sangdun Choi,et al. Doxorubicin Induces Cytotoxicity through Upregulation of pERK–Dependent ATF3 , 2012, PloS one.
[6] W. Wätjen,et al. Dose- and time-dependent effects of doxorubicin on cytotoxicity, cell cycle and apoptotic cell death in human colon cancer cells. , 2010, Toxicology.
[7] S. Khavari-Nejad,et al. Acriflavine‐Mediated Apoptosis and Necrosis in Yeast Candida utilis , 2009, Annals of the New York Academy of Sciences.
[8] I. Busnadiego,et al. Doxorubicin‐Induced MAPK Activation in Hepatocyte Cultures Is Independent of Oxidant Damage , 2006, Annals of the New York Academy of Sciences.
[9] A. Ballestrero,et al. Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase. , 2006, Cardiovascular research.
[10] E. Monti,et al. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin , 2004, BMC Cancer.
[11] E. Keyhani,et al. Plasma Membrane Alteration Is an Early Signaling Event in Doxorubicin‐Induced Apoptosis in the Yeast Candida utilis , 2004, Annals of the New York Academy of Sciences.
[12] F. Oesch,et al. Oxidative stress response of tumor cells: microarray-based comparison between artemisinins and anthracyclines. , 2004, Biochemical pharmacology.
[13] Ping H Wang,et al. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. , 2003, Journal of molecular and cellular cardiology.
[14] Cheryl Brantley-Finley,et al. The JNK, ERK and p53 pathways play distinct roles in apoptosis mediated by the antitumor agents vinblastine, doxorubicin, and etoposide. , 2003, Biochemical pharmacology.
[15] L. Hsu,et al. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. , 2002, Journal of molecular and cellular cardiology.
[16] C. Leeuwenburgh,et al. Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. , 2002, Cancer research.
[17] R. Reszka,et al. Mitochondria as subcellular targets for clinically useful anthracyclines. , 2001, Advanced drug delivery reviews.
[18] K. Webster,et al. Molecular mechanisms of apoptosis in the cardiac myocyte. , 2001, Current opinion in pharmacology.
[19] D. Green,et al. The central executioners of apoptosis: caspases or mitochondria? , 1998, Trends in cell biology.
[20] L. Gille,et al. The Exogenous NADH Dehydrogenase of Heart Mitochondria Is the Key Enzyme Responsible for Selective Cardiotoxicity of Anthracyclines , 1998, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[21] J. D. Young,et al. Cell suicide in health and disease. , 1996, Scientific American.
[22] C. Morris,et al. Adriamycin stimulates proliferation of human lymphoblastic leukaemic cells via a mechanism of hydrogen peroxide (H2O2) production , 1996, British journal of haematology.
[23] V. Ferrans,et al. Doxorubicin-induced apoptosis in spontaneously hypertensive rats: differential effects in heart, kidney and intestine, and inhibition by ICRF-187. , 1996, Journal of molecular and cellular cardiology.
[24] D. S. St. Clair,et al. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. , 1996, The Journal of clinical investigation.
[25] Y. J. Kang,et al. Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice (*) , 1996, The Journal of Biological Chemistry.
[26] H. Nohl,et al. A novel superoxide radical generator in heart mitochondria , 1987, FEBS letters.
[27] J. Doroshow. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. , 1983, Cancer research.
[28] J. Doroshow,et al. The effect of doxorubicin on hepatic and cardiac glutathione. , 1979, Research communications in chemical pathology and pharmacology.
[29] Amandeep Kaur,et al. Doxorubicin: a critical review on toxicity , 2016 .
[30] S. Khavari-Nejad,et al. Inhibition by doxorubicin of anti-ROS enzymes superoxide dismutase and catalase in Salmonella typhimurium , 2009 .
[31] 野堀 潔. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes : a novel cardioprotective role of ATF3 , 2004 .
[32] Y. J. Kang,et al. Inhibition of doxorubicin chronic toxicity in catalase-overexpressing transgenic mouse hearts. , 2002, Chemical research in toxicology.